health pharma news today obesity drugs glp-1 A new oral option is now part of medicine. FDA approved Foundayo (orforglipron), a once-daily oral GLP-1 receptor agonist, for adults with obesity or overweight with at least one weight-related WHO scientists endorse weight loss
Pay in 4 interest-free payments of $7.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28





















![[ Rei同款 Pre-order ] Hug Friends Cap Colour:Camo](https://cdn.shopify.com/s/files/1/0560/5428/4403/files/ABC6789A-7AD9-41E8-9BE8-9BD46410A7B1.webp?v=1741956267)




![[ Pre-order ] Threetimes Athletic silt skirt Colour:Black](https://cdn.shopify.com/s/files/1/0560/5428/4403/files/966E9CFA-8927-4A8F-B1C1-C211600C06EE.jpg?v=1722578158)